BAC vs ERNA · P/E 13, rev $113.10B vs P/E 0.0, rev $582.0K
Bank of America Corp (BAC) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Bank of America Corp (BAC) is a banks - diversified company listed on US. It is led by Brian Moynihan.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported BAC revenue for 2025-12-31 was $113.10B. Net income was $30.51B. Revenue was up 11.0% from 2024-12-31 to 2025-12-31. BAC currently screens at market cap $382.01B and trailing P/E 13.4.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
BAC currently screens at market cap $382.01B and trailing P/E 13.4. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the BAC and ERNA stock pages for the full models.
Not investment advice.